118 related articles for article (PubMed ID: 1279246)
1. [Current status of anti-HCV screening and posttransfusion hepatitis].
Kiyokawa H
Rinsho Byori; 1992 Sep; 40(9):925-8. PubMed ID: 1279246
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to hepatitis C virus in blood donors and their relationship to surrogate markers.
Hugo T; Wüst T; Beeser HP
Beitr Infusionsther; 1992; 30():49-52. PubMed ID: 1284765
[TBL] [Abstract][Full Text] [Related]
3. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
[TBL] [Abstract][Full Text] [Related]
4. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
7. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
8. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
9. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
[TBL] [Abstract][Full Text] [Related]
10. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
[TBL] [Abstract][Full Text] [Related]
11. [Detection of hepatitis C virus antibody in non-A non-B liver diseases].
Ishikawa K; Chiba T; Sato S
Rinsho Byori; 1991 Jan; 39(1):18-25. PubMed ID: 1848911
[TBL] [Abstract][Full Text] [Related]
12. Abbott HCV EIA 2nd generation: a new screening assay.
Weise W; Bäcker U; Seidl S; Flacke H; Sondag D; Pirenne H; Schroeter E; Troonen H; Broeksma C; Heyermann H
Beitr Infusionsther; 1992; 30():34-7. PubMed ID: 1284729
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis.
Takano S; Nakamura K; Kawai S; Yokosuka O; Satomura Y; Omata M
Hepatology; 1996 Apr; 23(4):708-12. PubMed ID: 8666321
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
15. [Viral hepatitis and blood transfusion].
Larsen J; Hetland G; Skaug K; Maeland A
Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
[TBL] [Abstract][Full Text] [Related]
16. [Transfusion aspects of viral hepatitis C].
Erceg S; Fabri M; Belić B; Jovanović R; Veselinović V
Med Pregl; 1996; 49(9-10):394-7. PubMed ID: 8999297
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of anti-HCV (C100-3) antibodies in 20.373 blood donors].
Zufferey C; Lavanchy D; Reiff M; Schneider P; Frei P; Pécoud A; Gonvers JJ
Schweiz Med Wochenschr; 1992 Oct; 122(41):1524-9. PubMed ID: 1411411
[TBL] [Abstract][Full Text] [Related]
18. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
[TBL] [Abstract][Full Text] [Related]
19. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
Busch MP; Korelitz JJ; Kleinman SH; Lee SR; AuBuchon JP; Schreiber GB
Transfusion; 1995; 35(11):903-10. PubMed ID: 8604486
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.
González A; Esteban JI; Madoz P; Viladomiu L; Genesca J; Muñiz E; Enríquez J; Torras X; Hernández JM; Quer J
Hepatology; 1995 Aug; 22(2):439-45. PubMed ID: 7635410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
